Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR01190
|
|||||
Drug Name |
Rescinnamine
|
|||||
Synonyms |
3,4,5-Trimethoxycinnamic acid, methyl reserpate; 3,4,5-Trimethoxycinnamoyl methyl reserpate; 3,4,5-Trimethylcinnamic acid, ester with methyl reserpate; 3,4,5-Trimethylcinnamoyl methyl reserpate; Anapral; Anaprel; Anaprel (TN); Apolon; Apoterin; Apoterin S; Cartric; Cinamine; Cinatabs; Cinnaloid; Cinnasil; Cinnasil (TN); Methyl 18-O-(3,4,5-trimethoxycinnamoyl)reserpate; Methyl reserpate 3,4,5-trimethoxycinnamic acid ester; Methyl trimethoxycinnamoylreserpate; Moderil; Moderil (TN); NP-011016; Normorescina; O-(3,4,5-Trimethoxy-trans-cinnamoyl) methyl reserpate; Paresinan; Raupyrol; Raurescin; Raurescine; Recinnamine; Recitensina; Rescaloid; Rescamin; Rescidan; Rescin; Rescinamina; Rescinamina [INN-Spanish]; Rescinnamin; Rescinnamina; Rescinnamina [DCIT]; Rescinnamine (JAN/INN); Rescinnamine (VAN); Rescinnamine [BAN:INN:JAN]; Rescinnaminum; Rescinnaminum [INN-Latin]; Rescinpal; Rescisan; Rescitens; Resealoid; Resepinine (C35 alkaloid); Reserpic acid methyl ester 3,4,5-trimethoxycinnamate; Reserpinene; Reserpinin; Reserpinine; Reserpinine (C35 alkaloid); Reserpinine (VAN); Resipal; Reskinnamin; Rozex; Scinnamina; Tenamine; Trimethoxy cinnamoyl reserpate de methyl; Trimethoxy cinnamoyl reserpate de methyl [French]; Trimethoxycinnamoyl methyl reserpate; Tsuruselpi S; Tsuruselpi S (TN); Tuareg
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antihypertensive Agents
|
|||||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C35H42N2O9
|
|||||
Canonical SMILES |
COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC
|
|||||
InChI |
InChI=1S/C35H42N2O9/c1-40-21-8-9-22-23-11-12-37-18-20-15-29(46-30(38)10-7-19-13-27(41-2)33(43-4)28(14-19)42-3)34(44-5)31(35(39)45-6)24(20)17-26(37)32(23)36-25(22)16-21/h7-10,13-14,16,20,24,26,29,31,34,36H,11-12,15,17-18H2,1-6H3/b10-7+/t20-,24+,26-,29-,31+,34+/m1/s1
|
|||||
InChIKey |
SZLZWPPUNLXJEA-QEGASFHISA-N
|
|||||
CAS Number |
CAS 24815-24-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 634.7 | Topological Polar Surface Area | 118 | ||
Heavy Atom Count | 46 | Rotatable Bond Count | 11 | |||
Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 10 | |||
XLogP |
4.5
|
|||||
PubChem CID | ||||||
PubChem SID |
10321534
, 103636520
, 103914025
, 121362993
, 124800786
, 134338187
, 134995503
, 135727524
, 137003688
, 137241862
, 141909708
, 14789939
, 164814309
, 178103676
, 179116876
, 184547043
, 198962755
, 226542531
, 241044490
, 251895606
, 252356449
, 39289912
, 46530467
, 47515483
, 47515484
, 47662471
, 47885571
, 48035309
, 48334675
, 48416513
, 48424034
, 49698557
, 49855219
, 56463114
, 57357943
, 597356
, 75304571
, 7847266
, 79429
, 8138008
, 85789351
, 85789400
, 8616456
, 8770
, 92125322
, 95156792
|
|||||
ChEBI ID |
ChEBI:28572
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.